ENTA - Enanta Pharma EPS beats by $0.06 misses on revenue November, 22 2021 04:04 PM Enanta Pharmaceuticals Inc. Enanta Pharma (NASDAQ:ENTA): FQ4 GAAP EPS of -$1.22 beats by $0.06. Revenue of $23.58M (-0.2% Y/Y) misses by $2.76M. Shares +0.38%. Press Release For further details see: Enanta Pharma EPS beats by $0.06, misses on revenue